Home » News from Countries » New cooperation between Stent for Life and Women in Innovation

New cooperation between Stent for Life and Women in Innovation

In January, the Women in Innovation (WIN) Initiative applied for affiliation to the SFL Initiative. Alaide Chieffo, MD, FSCAI, WIN Program Co-Chair, and Marie-Claude Morice, WIN Innovation Council Chair, tell us more about the WIN initiative and their projects with SFL.

What is the Women in Innovations (WIN) initiative?
WIN (women in innovation) is a large group of women interventional cardiologists and members of the industry. WIN is currently affiliated with both the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Society for Cardiovascular Angiography and Interventions (SCAI). The WIN mission is to address gender disparities in cardiovascular care and professionalism through education, research, professional development and innovation. This mission is in direct correlation with the Stent for Life objectives of increasing patient access to primary percutaneous coronary intervention (PCI) where indicated, and addressing unmet medical needs for the optimal treatment of acute coronary syndromes.

Which benefits do you see in the cooperation with Stent for Life?
WIN is hopeful that with its affiliation with Stent for Life it will be able to develop collaborative projects which address gender disparities in both access to cardiovascular care and treatment in targeted countries throughout Europe. WIN has a strong contingent of European members able to promote and facilitate such projects. With the participation of Stent for Life, WIN is confident that its efforts will become more successful and that the missions of both organisations will be met.

What projects are you currently undertaking with Stent for Life?
The collaboration has just begun. Thus far, in partnership with Stent for Life’s Spanish chapter and the Spanish Society of Cardiology, WIN earned 3rd prize in the 2011 ESC Women at Heart contest. As a result, WIN is about to launch a patient and provider education website and will gather data from both groups for further study about heart disease in women in Spain. In addition to the project in Spain, WIN has helped to organise a workshop during the SFL FORUM 2012 Conference (1-2 March, Prague) on the specificities and unmet needs for women with acute coronary syndromes. Based on these two first efforts, WIN hopes to work with Stent for Life to develop a broader educational campaign to reduce the delays of treatment for AMI, which are always longer in women than men, and to allow more women access to primary PCI in identified countries across Europe.

Alaide Chieffo, FSCAI, WIN Program Co-Chair
Marie-Claude Morice, WIN Innovation Council Chair